IWC
CERE

Integrated Wealth Concepts’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Integrated Wealth Concepts’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,050
Closed -$165K – 844
2021
Q1 		$165K Buy
+12,050
New +$176K 0.01% 703

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Integrated Wealth Concepts's CERE Position: Q2 2021 in Review

Integrated Wealth Concepts sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q2 2021, closing a stake of 12,050 shares — an estimated $165K sold.

Integrated Wealth Concepts first reported a position in CERE in Q1 2021 and held it in 1 quarter. The position peaked at $165K in Q1 2021. 82 funds tracked by Wall St. Rank hold CERE as of Q2 2021.

  • Integrated Wealth Concepts reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Integrated Wealth Concepts sold 12,050 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q2 2021, an estimated $165K.
  • Integrated Wealth Concepts first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Integrated Wealth Concepts's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $165K in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q2 2021.

Based on Integrated Wealth Concepts's 13F filing for Q2 2021, filed 13 Aug 2021.